Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes

Journal of Hospital Infection

Volumn 64, Issue 2, 2006, Pages 169-176

  Ozkocaman, V ^a   Ozcelik, T ^a   Ali, R ^a   Ozkalemkas, F ^a   Ozkan, A ^a   Ozakin, C ^a   Akalin, H ^a   Ursavas, A ^a   Coskun, F ^a   Ener, B ^a   Tunali, A ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Acute leukaemia; Antibiotics; Bacillus spp. infections; Cancer; Febrile neutropenia; Lymphoma

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ABDOMINAL PAIN; ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS; BACILLUS CEREUS; BACILLUS LICHENIFORMIS; BACILLUS PUMILUS; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATION; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; COTTON; DISEASE SEVERITY; EPIDEMIC; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HOSPITAL PATIENT; HUMAN; LIVER DYSFUNCTION; MALE; MORBIDITY; MORTALITY; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; SALVAGE THERAPY; SKIN DECONTAMINATION; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; WOOL; CROSS INFECTION; HEMATOLOGY; HOSPITAL SUBDIVISIONS AND COMPONENTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TURKEY (REPUBLIC);

ACINETOBACTER BAUMANNII; ADULT; AGED; AGED, 80 AND OVER; BACILLUS; BACTEREMIA; CROSS INFECTION; DISEASE OUTBREAKS; ESCHERICHIA COLI; FEMALE; HEMATOLOGY; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; TURKEY;

EID: 33750620537     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.05.014     Document Type: Article

References (40)

1. Bow E.J. Management of the febrile neutropenic cancer patient: lessons from 40 years of study. Clin Microbiol Infect 11 Suppl. 5 (2005) 24-29
2. Sipsas N.V., Bodey G.P., and Kontoyiannis D.P. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 103 (2005) 1103-1113
3. Viscoli C., Varnier O., and Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 40 Suppl. 4 (2005) S240-S245
4. Akova M., Paesmans M., Calandra T., and Viscoli C. International Antimicrobial Therapy Group of the European Organization for Research and Treatment of Cancer. A European Organization for Research and Treatment of Cancer international antimicrobial therapy group study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis 40 (2005) 239-245
5. Zinner S.H. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 29 (1999) 490-494
6. Ginsburg A.S., Salazar L.G., True L.D., and Disis M.L. Fatal Bacillus cereus sepsis following resolving neutropenic enterocolitis during the treatment of acute leukemia. Am J Hematol 72 (2003) 204-208
7. Drobniewski F.A. Bacillus cereus and related species. Clin Microbiol Rev 6 (1993) 324-338
8. Cotton D.J., Gill V.J., Marshall D.J., Gress J., Thaler M., and Pizzo P.A. Clinical features and therapeutic interventions in 17 cases of Bacillus bacteremia in an immunosuppressed patient population. J Clin Microbiol 25 (1987) 672-674
9. Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
10. Link H., Bohme A., Cornely O.A., et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82 Suppl. 2 (2003) S105-S117
11. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 7th ed. (2000), NCCLS, Wayne, PA Approved standard M2-A7
12. Frankard J., Li R., Taccone F., Struelens M.J., Jacobs F., and Kentos A. Bacillus cereus pneumonia in a patient with acute lymphoblastic leukemia. Eur J Clin Microbiol Infect Dis 23 (2004) 725-728
13. Banerjee C., Bustamante C.I., Wharton R., Talley E., and Wade J.C. Bacillus infections in patients with cancer. Arch Intern Med 148 (1988) 1769-1774
14. Gaur A.H., Patrick C.C., McCullers J.A., et al. Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin Infect Dis 32 (2001) 1456-1462
15. Arnaout M.K., Tamburro R.F., Bodner S.M., et al. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Pediatr Hematol Oncol 21 (1999) 431-435
16. Kobayashi K., Kami M., Ikeda M., et al. Fulminant septicemia caused by Bacillus cereus following reduced-intensity umbilical cord blood transplantation. Haematologica 90 (2005) ECR06
17. Weber D.J., Saviteer S.M., Rutala W.A., and Thomann C.A. In vitro susceptibility of Bacillus spp. to selected antimicrobial agents. Antimicrob Agents Chemother 32 (1988) 642-645
18. Hsueh P.R., Teng L.J., Yang P.C., Pan H.L., Ho S.W., and Luh K.T. Nosocomial pseudoepidemic caused by Bacillus cereus traced to contaminated ethyl alcohol from a liquor factory. J Clin Microbiol 37 (1999) 2280-2284
19. Dubouix A., Bonnet E., Alvarez M., et al. Bacillus cereus infections in traumatology-orthopaedics department: retrospective investigation and improvement of healthcare practices. J Infect 50 (2005) 22-30
20. Galanos J., Perera S., Smith H., O'Neal D., Sheorey H., and Waters M.J. Bacteremia due to three Bacillus species in a case of Munchausen's syndrome. J Clin Microbiol 41 (2003) 2247-2248
21. Latsios G., Petrogiannopoulos C., Hartzoulakis G., Kondili L., Bethimouti K., and Zaharof A. Liver abscess due to Bacillus cereus: a case report. Clin Microbiol Infect 9 (2003) 1234-1237
22. Miller J.M., Hair J.G., Hebert M., Hebert L., and Roberts Jr. F.J. Fulminating bacteremia and pneumonia due to Bacillus cereus. J Clin Microbiol 35 (1997) 504-507
23. Strauss R., Mueller A., Wehler M., et al. Pseudomembranous tracheobronchitis due to Bacillus cereus. Clin Infect Dis 33 (2001) e39-e41
24. Mori T., Tokuhira M., Takae Y., et al. Successful non-surgical treatment of brain abscess and necrotizing fasciitis caused by Bacillus cereus. Intern Med 41 (2002) 671-673
25. Cone L.A., Dreisbach L., Potts B.E., Comess B.E., and Burleigh W.A. Fatal Bacillus cereus endocarditis masquerading as an anthrax-like infection in a patient with acute lymphoblastic leukemia: case report. J Heart Valve Dis 14 (2005) 37-39
26. Matsumoto S., Suenaga H., Naito K., Sawazaki M., Hiramatsu T., and Agata N. Management of suspected nosocomial infection: an audit of 19 hospitalized patients with septicemia caused by Bacillus species. Jpn J Infect Dis 53 (2000) 196-202
27. Hilliard N.J., Schelonka R.L., and Waites K.B. Bacillus cereus bacteremia in a preterm neonate. J Clin Microbiol 41 (2003) 3441-3444
28. Adler A., Gottesman G., Dolfin T., et al. Bacillus species sepsis in the neonatal intensive care unit. J Infect 51 (2005) 390-395
29. Kotiranta A., Lounatmaa K., and Haapasalo M. Epidemiology and pathogenesis of Bacillus cereus infections. Microbes Infect 2 (2000) 189-198
30. Salkinoja-Salonen M.S., Vuorio R., Andersson M.A., et al. Toxigenic strains of Bacillus licheniformis related to food poisoning. Appl Environ Microbiol 65 (1999) 4637-4645
31. Mikkola R., Kolari M., Andersson M.A., Helin J., and Salkinoja-Salonen M.S. Toxic lactonic lipopeptide from food poisoning isolates of Bacillus licheniformis. Eur J Biochem 267 (2000) 4068-4074
32. Blue S.R., Singh V.R., and Saubolle M.A. Bacillus licheniformis bacteremia: five cases associated with indwelling central venous catheters. Clin Infect Dis 20 (1995) 629-633
33. Castagnola E., Fioredda F., Barretta M.A., et al. Bacillus sphaericus bacteraemia in children with cancer: case reports and literature review. J Hosp Infect 48 (2001) 142-145
34. Liu P.Y.F., Ke S.C., and Chen S.L. Use of pulsed-field gel electrophoresis to investigate a pseudo-outbreak of Bacillus cereus in a pediatric unit. J Clin Microbiol 35 (1997) 1533-1535
35. York M.K. Bacillus species pseudobacteremia traced to contaminated gloves used in collection of blood from patients with acquired immunodeficiency syndrome. J Clin Microbiol 28 (1990) 2114-2116
36. Thomas P. Isolation of Bacillus pumilus from in vitro grapes as a long-term alcohol-surviving and rhizogenesis inducing covert endophyte. J Appl Microbiol 97 (2004) 114-123
37. Berger S.A. Pseudobacteremia due to contaminated alcohol swabs. J Clin Microbiol 18 (1983) 974-975
38. Loeb M., Wilcox L., Thornley D., Gun-Munro J., and Richardson H. Bacillus species pseudobacteremia following hospital construction. Can J Infect Control 10 (1995) 37-40
39. El Saleeby C.M., Howard S.C., Hayden R.T., and McCullers J.A. Association between tea ingestion and invasive Bacillus cereus infection among children with cancer. Clin Infect Dis 39 (2004) 1536-1539
40. From C., Pukall R., Schumann P., Hormazabal V., and Granum P.E. Toxin-producing ability among Bacillus spp. outside the Bacillus cereus group. Appl Environ Microbiol 71 (2005) 1178-1183